REVIEW SERIES

₁-Antitrypsin deficiency · 6: New and emerging treatments for ₁-antitrypsin deficiency

R A Sandhaus

National Jewish Medical and Research Center, Denver, Colorado, and AlphaNet Inc, Miami, Florida, USA

Correspondence to:
Correspondence to:
Dr R Sandhaus
Professor of Medicine, Director, Alpha-1 Program, National Jewish Medical and Research Center, Southside Building G106, 1400 Jackson Street, Denver, CO 80206, USA; rasandhaus{at}alphaone.org

Alpha-1-antitrypsin (AAT) deficiency is a genetic condition that increases the risk of developing lung and liver disease, as well as other associated conditions. Most treatment of affected individuals is not specifically directed at AAT deficiency but focuses on the resultant disease state. The only currently available specific therapeutic agent—namely, intravenous augmentation with plasma derived AAT protein—is marketed in a limited number of countries. Treatments aimed at correcting the underlying genetic abnormality, supplementing or modifying the gene product, and halting or reversing organ injury are now beginning to emerge. These innovative approaches may prove effective at modifying or eliminating diseases association with AAT deficiency.

Keywords: 1-antitrypsin deficiency; treatment

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Airwaves

Wisia Wedzicha
Thorax 2004 59: 821a. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Celli, B. R. (2008). Update on the Management of COPD. Chest 133: 1451-1462 [Abstract] [Full Text]  
• Zamora, N. P., Pla, R. V., Del Rio, P. G., Margaleff, R. J., Frias, F. R., Ronsano, J. B. M. (2008). Intravenous Human Plasma-Derived Augmentation Therapy in {alpha}1-Antitrypsin Deficiency: From Pharmacokinetic Analysis to Individualizing Therapy. The Annals of Pharmacotherapy 42: 640-646 [Abstract] [Full Text]  
• Trotta, B. M., Stolin, A. V., Williams, M. B., Gay, S. B., Brody, A. S., Altes, T. A. (2007). Characterization of the Relation Between CT Technical Parameters and Accuracy of Quantification of Lung Attenuation on Quantitative Chest CT. Am. J. Roentgenol. 188: 1683-1690 [Abstract] [Full Text]  
• Wedzicha, J A, Howard, E C, Johnston, S L, Mitchell, D M (2005). Thorax Annual Report October 2004-September 2005. Thorax 60: 987-988 [Full Text]  
• Barnes, P. J., Stockley, R. A. (2005). COPD: current therapeutic interventions and future approaches. Eur Respir J 25: 1084-1106 [Abstract] [Full Text]  
• Fishman, A. P. (2005). One Hundred Years of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 171: 941-948 [Full Text]